Episode 202 | Beyond the Shot: Vaccines, Practice Profitability & Patient Care with Mike Myers

Vaccines are one of medicine's greatest public health achievements—but for today's physician practices, they're also becoming increasingly complex to manage. Between changing recommendations, reimbursement challenges, inventory costs, and patient education, vaccination programs require thoughtful clinical and business leadership. In this episode of Medical Money Matters, Jill Arena welcomes Michael Myers, MD, MBA, physician executive, author, and nationally recognized expert in primary care, public health, and healthcare leadership. Dr. Myers discusses his new book, The Vaccine Bible, sharing why he wrote it, the knowledge gaps he hopes to address, and what physicians need to understand as the vaccine landscape continues to evolve. Together, Jill and Dr. Myers explore how vaccine programs affect the financial health of medical practices, practical strategies for navigating reimbursement and operations, and how physicians can have productive conversations with patients while maintaining trust and delivering high-quality care. Whether you're in private practice, employed by a health system, or leading a medical group, this conversation offers practical insights into balancing clinical excellence with sound business management. Please Follow or Subscribe to get new episodes delivered to you as soon as they drop! Visit Jill’s company, Health e Practices’ website: https://healtheps.com/ Subscribe to our newsletter, Health e Connections: http://21978609.hs-sites.com/newlette... Want more content? Find sample job descriptions, financial tools, templates and much more: https://www.MedicalMoneyMattersPodcas... Purchase your copy of Jill’s book here:https://smile.amazon.com/Physician-He... Join our Medical Money Matters Facebook Group here:   / 3834886643404507   Original Musical Score by: Craig Addy at https://www.underthepiano.ca/ Visit Craig’s website to book your Once in a Lifetime music experience Podcast coaching and development by: Jennifer Furlong, CEO, Communication Twenty-Four Seven https://www.communicationtwentyfourse...